We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
VSE Corp
VSEC
$6.12B
| $463K | ﹤0.01% |
14,763
-640
| -4% | -$14.6K |
|
2377
West Bancorporation
WTBA
$485M
| $463K | ﹤0.01% |
26,473
-3,525
| -12% | -$60.8K |
|
2378
Axogen
AXGN
$2.5B
| $462K | ﹤0.01% |
49,978
+3,853
| +8% | +$34.5K |
|
2379
Bank First Corp
BFC
$1.7B
| $461K | ﹤0.01% |
7,199
+1,075
| +18% | +$61.7K |
|
2380
Accel Entertainment
ACEL
$987M
| $459K | ﹤0.01% |
+47,689
| New | +$436K |
|
2381
Sierra Bancorp
BSRR
$525M
| $459K | ﹤0.01% |
24,315
-1,555
| -6% | -$28K |
|
|
WTRE
2382
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $459K | ﹤0.01% |
27,487
-2,125
| -7% | -$30.5K |
|
2383
Citizens & Northern Corp
CZNC
$455M
| $457K | ﹤0.01% |
22,135
-1,210
| -5% | -$22.8K |
|
|
MOFG
2384
DELISTED
MidWestOne Financial Group
MOFG
| $457K | ﹤0.01% |
22,841
+2,380
| +12% | +$45.9K |
|
2385
Ooma
OOMA
$604M
| $457K | ﹤0.01% |
27,752
+2,393
| +9% | +$29.9K |
|
|
ALBO
2386
DELISTED
Albireo Pharma Inc
ALBO
| $457K | ﹤0.01% |
17,242
+3,445
| +25% | +$81.3K |
|
2387
Caesarstone
CSTE
$79.5M
| $456K | ﹤0.01% |
38,472
+1,726
| +5% | +$18.2K |
|
|
CNCE
2388
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $456K | ﹤0.01% |
45,815
+5,466
| +14% | +$52.4K |
|
|
TRUE
2389
DELISTED
TrueCar
TRUE
| $455K | ﹤0.01% |
176,527
+40,636
| +30% | +$104K |
|
2390
CNB Financial Corp
CCNE
$1.03B
| $453K | ﹤0.01% |
25,266
+2,075
| +9% | +$35.1K |
|
2391
ImmunityBio
IBRX
$8.1B
| $453K | ﹤0.01% |
+36,899
| New | +$208K |
|
2392
Veritone
VERI
$122M
| $451K | ﹤0.01% |
+30,335
| New | +$255K |
|
2393
NextCure
NXTC
$26.7M
| $450K | ﹤0.01% |
1,751
+304
| +21% | +$116K |
|
|
EBTC
2394
DELISTED
Enterprise Bancorp
EBTC
| $449K | ﹤0.01% |
18,829
+730
| +4% | +$16.9K |
|
2395
Peoples Financial Services
PFIS
$707M
| $448K | ﹤0.01% |
11,725
-2,160
| -16% | -$75K |
|
|
CNR
2396
Core Natural Resources Inc
CNR
$4.45B
| $447K | ﹤0.01% |
88,078
-8,796
| -9% | -$54.9K |
|
|
AMRS
2397
DELISTED
Amyris Inc.
AMRS
| $447K | ﹤0.01% |
104,601
+22,476
| +27% | +$74.7K |
|
|
MTEM
2398
DELISTED
Molecular Templates, Inc.
MTEM
| $443K | ﹤0.01% |
2,141
+607
| +40% | +$141K |
|
|
LORL
2399
DELISTED
Loral Space and Communications, Inc.
LORL
| $443K | ﹤0.01% |
22,683
+4,624
| +26% | +$86.6K |
|
2400
CRA International
CRAI
$1.06B
| $440K | ﹤0.01% |
11,148
-1,502
| -12% | -$57K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.